ProJenX
Operator of a clinical-stage biopharmaceutical company intended to treat neurodegenerative diseases. The company develops oral, brain-penetrant, small molecules shown in multiple laboratory models tha...
Valuation
$0
Share Price
N/A
Total Raised
$21M
Last Round
N/A